Shooting Cancer

21 12, 2023

Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology –November 2023

adlitterio663392023-12-21T10:04:23+01:00

28 06, 2023

Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – April and May 2023

adlitterio663392023-06-28T10:22:08+02:00

1 04, 2023

Shooting Cancer Highlights – Monthly focus on regulatory status of new targeted therapies in oncology – February and March 2023

adlitterio663392023-06-28T10:51:22+02:00

2 03, 2023

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – January 2023

adlitterio663392023-03-02T10:16:43+01:00

11 01, 2023

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – November and December 2022

adlitterio663392023-01-11T12:13:39+01:00

15 11, 2022

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – October 2022

adlitterio663392023-04-06T11:41:01+02:00

10 10, 2022

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – September 2022

adlitterio663392022-10-11T16:23:17+02:00

4 08, 2022

Shooting Cancer- Highlights Monthly focus on regulatory status of new targeted therapies in oncology – July 2022

adlitterio663392022-08-04T09:42:52+02:00

18 07, 2022

Monthly focus on regulatory status of new targeted therapies in oncology – June 2022

adlitterio663392022-07-18T11:28:45+02:00

20 05, 2022

Monthly focus on regulatory status of new targeted therapies in oncology – April 2022

Diatech Pharmacogenetics2022-05-20T11:08:27+02:00